NCT04893590

Brief Summary

Persons with disabilities (PwD) commonly experience fatigue, which often negatively impacts their everyday lives. Management of this symptom can be challenging. Satisfaction with current interventions to manage fatigue is low among PwD and there is a desire for more personalized approaches. The purpose of this study is to develop and test a fatigue self-management intervention using mobile phones that is personalized to each person's needs.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
27

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started May 2021

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 14, 2021

Completed
Same day until next milestone

Study Start

First participant enrolled

May 14, 2021

Completed
5 days until next milestone

First Posted

Study publicly available on registry

May 19, 2021

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 28, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 28, 2022

Completed
Last Updated

March 28, 2025

Status Verified

March 1, 2025

Enrollment Period

10 months

First QC Date

May 14, 2021

Last Update Submit

March 24, 2025

Conditions

Keywords

FatiguePersons with disabilitiesPatient activationMobile health

Outcome Measures

Primary Outcomes (1)

  • Patient Activation - change in knowledge, skill and confidence for self-management

    The Patient Activation Measure (PAM-13) assesses four levels of activation: (1) the patient is disengaged and overwhelmed, (2) the patient is becoming aware but still struggling, (3) the patient takes action, and (4) the patient maintains behaviors. The psychometric properties of the PAM have been assessed in multiple healthcare settings. Raw PAM scores can be transformed into a continuous (0-100) scale, where higher scores represent higher levels of patient activation. In order to target self-management strategies, participants will proceed through these levels.

    Baseline and up to 2 weeks post intervention

Secondary Outcomes (2)

  • The Patient-Reported Outcomes Measurement Information System (PROMIS) - Fatigue Short Form 8a

    Baseline and up to 2 weeks post intervention

  • The Patient-Reported Outcomes Measurement Information System (PROMIS) - Sleep Disturbance Short Form 8a

    Baseline and up to 2 weeks post intervention

Study Arms (1)

Fatigue self-management SMS intervention

EXPERIMENTAL

The participants will receive a 12-week fatigue self-management SMS text intervention using mobile phones to target patient activation levels in people with disabilities.

Behavioral: Fatigue self-management SMS intervention

Interventions

Participants will set up an initial goal for the SMS intervention related to fatigue management, and prior to beginning the intervention they will be trained to use the SMS system. Participants will receive text messages each day, providing tips and techniques to help self-manage fatigue. Weekly the participants will be asked to provide feedback regarding their fatigue levels and their patient activation will be re-assessed at the halfway point of intervention.

Fatigue self-management SMS intervention

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years of age or older
  • had disability for at least one year
  • score of less than 10 on the Modified Fatigue Impact Scale 5 question (MFIS-5)
  • ability to read and speak English at the 6th grade level
  • willing to use their own phone and SMS

You may not qualify if:

  • evidence of acute condition (e.g. relapse)
  • sleep apnea
  • inability to answer interview questions or provide consent
  • terminal cancer

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Washington University School of Medicine

St Louis, Missouri, 63108, United States

Location

MeSH Terms

Conditions

Spinal Cord InjuriesStrokeMultiple SclerosisFatiguePatient Participation

Condition Hierarchy (Ancestors)

Spinal Cord DiseasesCentral Nervous System DiseasesNervous System DiseasesTrauma, Nervous SystemWounds and InjuriesCerebrovascular DisordersBrain DiseasesVascular DiseasesCardiovascular DiseasesDemyelinating Autoimmune Diseases, CNSAutoimmune Diseases of the Nervous SystemDemyelinating DiseasesAutoimmune DiseasesImmune System DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsPatient Acceptance of Health CareTreatment Adherence and ComplianceHealth BehaviorBehavior

Study Officials

  • Kerri Morgan, PhD

    Washington University School of Medicine

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor of Occupation Therapy and Neurology

Study Record Dates

First Submitted

May 14, 2021

First Posted

May 19, 2021

Study Start

May 14, 2021

Primary Completion

February 28, 2022

Study Completion

February 28, 2022

Last Updated

March 28, 2025

Record last verified: 2025-03

Locations